The Delaware facility will ensure a domestic supply of biologic drugs including the cancer drug Keytruda.

According to Merck, the total investment is now expected to be over $1 billion, with 500 full-time jobs and 4,000 ...

Seven weeks after opening a new $1 billion vaccine manufacturing facility in North Carolina, Merck has revealed that it is breaking ground on another $1 billion plant—this one in Wilmington ...

Merck (NYSE:MRK) has broken ground on a $1 billion facility in Wilmington, Delaware, becoming the latest pharmaceutical company to boost domestic investment as industry-targeted tariffs loom.

Merck Animal Health is investing $895 million in a new De Soto facility, which will bring hundreds of jobs to the area. The ...

Merck is constructing a $1 billion drug manufacturing facility in Wilmington, Delaware, as part of its commitment to investment and growth in the United States. The company on Tuesday said it ...

April 29 (Reuters) - U.S. drugmaker Merck (MRK.N), opens new tab said on Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with ...

A new manufacturing plant in De Soto will be a Center of Excellence for the global company, along with expanded R&D capabilities at the site.

German healthcare and materials group Merck KGaA has dropped a surcharge on life sciences sector orders within China ...